SARAH BELL: Open Payments
NPI 1982352944 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$504 in 26 payments from 8 companies in 2025. Trend: 2023 $404 · 2024 $422 · 2025 $504
Food & beverage: $485Education: $19
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 11 | $246 |
| ABBVIE INC. | 5 | $82 |
| Novo Nordisk Inc | 3 | $44 |
| Otsuka America Pharmaceutical, Inc. | 2 | $39 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $34 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $21 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $19 |
Products named: FARXIGA, AIRSUPRA, UBRELVY, Ozempic, BREZTRI, REXULTI, CAPLYTA, TRINTELLIX.
Industry payments across TN — which companies pay providers there.
